| Reference | Species | Other Genes Addressed |
|---|
Arendrup MC, et al. (2023) European candidaemia is characterised by notable differential epidemiology and susceptibility pattern; Results from the ECMM Candida III study. J Infect CGD Papers Entry Pubmed Entry | C. albicans | |GSC1 |GSL1 |ITS1 |ITS2 |
| C. glabrata | |FKS1 |ITS1 |ITS2 |
| C. parapsilosis | |FKS1 |ITS1 |ITS2 |
| C. dubliniensis | |ITS1 |ITS2 |
Czajka KM, et al. (2023) Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species. Cells 12(22) CGD Papers Entry Pubmed Entry | C. auris | |CDR1 |CDR2 |ERG11 |FKS1 |MDR1 |MRR1 |SNQ2 |
| C. albicans | |ALS3 |BGL2 |CDR1 |CDR2 |DDR48 |ERG11 |ERG25 |ERG3 |ERG5 |ERG6 |FCY2 |FCY21 |FUR1 |FZO1 |MORE |
| C. glabrata | |CDR1 |ERG11 |FCY1 |FCY2 |FKS1 |FUR1 |PDH1 |PDR1 |PDR16 |SNQ2 |
Szekely J, et al. (2023) Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak. Epidemiol Infect 151:e146 CGD Papers Entry Pubmed Entry | C. albicans | |GSC1 |GSL1 |
| C. glabrata | |FKS1 |
| C. parapsilosis | |FKS1 |
Diaz-Garcia J, et al. (2021) Antifungal Susceptibility Testing Identifies the Abdominal Cavity as a Source of Candida glabrata-Resistant Isolates. Antimicrob Agents Chemother 65(12):e0124921 CGD Papers Entry Pubmed Entry | C. glabrata | |ERG11 |FKS1 |
| C. albicans | |ERG11 |GSC1 |GSL1 |
Lim HJ, et al. (2020) Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species. Antimicrob Agents Chemother 64(11) CGD Papers Entry Pubmed Entry | C. glabrata | |FKS1 |PDR1 |
| C. albicans | |ERG11 |GSC1 |GSL1 |
| C. parapsilosis | |ERG11 |
Shaw KJ and Ibrahim AS (2020) Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections. J Fungi (Basel) 6(4) CGD Papers Entry Pubmed Entry | C. dubliniensis | |GWT1 |
| C. parapsilosis | |GWT1 |
| C. glabrata | |FKS1 |GWT1 |PDR1 |
| C. albicans | |CDR11 |GWT1 |SNQ2 |
Sakagami T, et al. (2019) Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital. J Infect Chemother 25(1):34-40 CGD Papers Entry Pubmed Entry | C. glabrata | |FKS1 |
| C. albicans | |GSC1 |GSL1 |GSL2 |
Xiao M, et al. (2018) Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms. Infect Drug Resist 11:155-161 CGD Papers Entry Pubmed Entry | C. glabrata | |FKS1 |
Pfaller MA, et al. (2015) Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012). J Antibiot (Tokyo) 68(9):556-61 CGD Papers Entry Pubmed Entry | C. glabrata | |FKS1 |
Castanheira M, et al. (2014) Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections. Int J Antimicrob Agents 44(4):320-6 CGD Papers Entry Pubmed Entry Reference LINKOUT | C. glabrata | |FKS1 |
Castanheira M, et al. (2010) Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains. Antimicrob Agents Chemother 54(6):2655-9 CGD Papers Entry Pubmed Entry Reference LINKOUT | C. albicans | |GSC1 |GSC1 |GSL2 |GSL2 |
| C. glabrata | |FKS1 |